Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash Flows From Operating Activities:
Net loss	$ (4,524,014)	$ (3,250,711)
Adjustments to reconcile net loss to cash used in operating activities
Change in fair value of warrant liability	(275,969)	(3,813,000)
Stock-based compensation	768,619	3,591,565
Inducement expense		298,714
Amortization of right-of-use asset	34,455
Amortization of intangible assets	42,188	136,640
Depreciation expense	27,077
Change in operating assets and liabilities:
Prepaid expenses and other current assets	(588,975)	(66,208)
Accounts payable and accrued liabilities	6,021	(59,278)
Right-of-use operating lease liability	(38,343)
Net cash used in operating activities	(4,548,941)	(3,162,278)
Cash Flows From Investing Activities:
Purchases of property and equipment	(505,507)
Purchase of license agreement		(675,000)
Net cash used in investing activities	(505,507)	(675,000)
Cash Flows From Financing Activities:
Proceeds from sale of common stock and warrants, net of offering costs	9,397,884	21,614,488
Proceeds from warrant exercises		3,267,245
Net cash provided by financing activities	9,397,884	24,881,733
Effect of foreign exchange rate on cash	(4,900)	34,235
Net increase in cash	4,338,536	21,078,690
Cash at beginning of period	17,355,999	1,578,460
Cash at end of period	21,694,535	22,657,150
Supplemental disclosure of cash flow information:
Cash paid for interest	4,138
Supplemental disclosure of non-cash investing and financing activities:
Warrants issued in conjunction with common stock issuance	$ 3,595,420